Connecticut Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 12 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 5,376
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 88.28%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 301
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 92.52%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 10.10% 6.31%
White, Hispanic/Latino Patients 15.83% 12.96%
Black/African American, Non-Hispanic/Latino Patients 26.60% 28.90%
Black/African American, Hispanic/Latino Patients 2.42% 2.99%
Asian Patients3 1.58% 0.33%
American Indian/Alaska Native Patients3 0.26% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.69% 0.33%
Patients with More than one race3 2.46% 1.33%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 26.23% 31.23%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.03% 1.66%
Unreported/Refused to Report Race and Ethnicity 10.81% 13.95%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,203
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 88.90%
COVID-19 Immunization Series Completed 3,493
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 86.47%
COVID-19 Immunization Series Additional 59
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 52.94%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 9.03% 11.34% 40.68%
White, Hispanic/Latino Patients 14.57% 16.63% 8.47%
Black/African American, Non-Hispanic/Latino Patients 19.84% 18.67% 16.95%
Black/African American, Hispanic/Latino Patients 3.27% 2.46% 3.39%
Asian Patients3 0.77% 1.66% 3.39%
American Indian/Alaska Native Patients3 0.45% 0.37% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.68% 0.40% 1.69%
Patients with More than one race3 1.82% 1.77% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 30.91% 30.49% 11.86%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.08% 6.78% 5.08%
Unreported/Refused to Report Race and Ethnicity 10.58% 9.42% 8.47%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 33.33%
More Than 24 Hours 58.33%
N/A 8.33%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 16.67%
Staffing to administer the vaccine 25.00%
Vaccine confidence 41.67%
Vaccine storage capacity 0.00%
Vaccine supply 16.67%
Other 0.00%
None 33.33%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 105.83%
Average Percent of Health Center Visits Conducted Virtually 32.50%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 58.33%
Number of Mobile Van Sites 12
Number of Pop-up Clinics 99
Number of School-Based Vaccination Sites 18

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 75.00%
None 25.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 8.33%
Other 16.67%
None 75.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021